Skip to content
DataLookout
Menu

NCT04782817

Reducing Reintubation Risk in High-Risk Cardiac Surgery Patients With High-Flow Nasal Cannula

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 15 versions: 14 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Results posted: Oct 27, 2026 Show 5 more changesShow less
    • Primary endpoint revised
    • Eligibility criteria expanded, about 5 words
    • Interventions: Provider choice standard care order set (Other), Recommendation for high flow nasal cannula oxygen therapy order set (Other) to Provider choice usual care order set (Other), Recommendation for high flow nasal cannula oxygen therapy order set (Other)
    • Secondary endpoints: 8 to 7
    • Publications: details revised at 12 of 13 entries
  2. Minor Trial completed
    • Study completion pushed from Mar 2026 to Apr 14, 2026
    v14
  3. Minor Enrollment target: estimated 3400 to confirmed 3568v13
  4. Minor Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Nov 1, 2025 to Nov 19, 2025
    • Study completion date: Dec 1, 2025 to Mar 2026
    • Site details revised
    v12
  5. Notable Eligibility criteria expanded, about 22 words
    • Enrollment target: 3192 to 3400
    • Secondary endpoints: 7 to 8
    • Study description shortened, about 40 words
    v11
Show 8 earlier versionsHide 8 earlier versions
  1. Minor Site contact updatedv10
  2. Notable Primary completion date: Nov 1, 2023 to Nov 1, 2025v8
  3. Minor Secondary endpoints: 3 to 7v7
  4. Notable Eligibility criteria expanded, about 15 wordsv6
  5. Minor Primary completion date: Nov 2023 to Nov 1, 2023
    • Study completion date: Nov 2023 to Dec 1, 2025
    v5
  6. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Aug 2023 to Nov 2023
    • Start date changed from estimate of Sep 2021 to Nov 1, 2021
    • Site details revised
    v4
  7. Notable Enrollment target: 1078 to 3192v3 Show 7 more changesShow less
    • Start date: Jul 2021 to Sep 2021
    • Eligibility criteria expanded, about 12 words
    • Primary endpoint revised
    • Primary and study completion dates: Jul 2023 to Aug 2023
    • Interventions: High flow nasal cannula oxygen therapy (Other), Provider choice standard care (Other) to Provider choice standard care order set (Other), Recommendation for high flow nasal cannula oxygen therapy order set (Other)
    • Secondary endpoints revised (3)
    • Study description expanded, about 15 words
  8. Notable Start date: Apr 2021 to Jul 2021
    • Primary and study completion dates pushed to Jul 2023
    v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Number of Participants With Reintubation Within 48 Hours of Extubation
Timeframe: 48 hours

Secondary (7)

Number of Participants With Reintubation Within 72 Hours of Extubation
Number of Participants With Reintubation After Cardiac Surgery
Number of Participants With All Cause Mortality
Hospital Length of Stay
Intensive Care Unit Length of Stay
Show 2 moreShow less
Ventilator-free Days
Number of Participants With In-hospital Mortality

Arms and interventions

High Flow Nasal Canula Oxygen TherapyExperimental

Participants will be assigned post extubation physician order set which recommends the administration of oxygen therapy via HFNC. HFNC is a heated and humidified system that allows prescribed fraction of inspired oxygen (FIO2) levels to be delivered at very high flow rates.

Provider Choice Usual CareActive comparator

Participants be assigned standard provider choice of usual care therapy physician order set.

Other: Recommendation for high flow nasal cannula oxygen therapy order set, Provider choice usual care order set

Sites

1 site in 1 country

  • Vanderbilt University Medical CenterNashville, Tennessee, United States